A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)

NCT02653391 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Fuchs' Corneal Endothelial Dystrophy (FCED)

Interventions

DRUG: Part A Elamipretide 1.0% Ophthalmic Solution
DRUG: Part B Elamipretide 3.0% Ophthalmic Solution
DRUG: Part A Placebo
DRUG: Part B Placebo

Sponsor

Stealth BioTherapeutics Inc.